Aclaris Therapeutics, Inc.

ACRS·NASDAQ·$4.51Share Price as of 11/2·$544MMarket Cap as of 11/2

Financials

10-QQ2 ended 06/30/2608/06/26 10-QQ1 ended 03/31/2605/07/26 10-KFY 202502/26/26 10-QQ3 ended 09/30/2511/06/25 10-QQ2 ended 06/30/2508/07/25

Disclosures

8-KCurrent report10/27/26 8-KCurrent report10/27/26 8-KCurrent report08/06/26 8-KResults of Operations08/06/26 8-KCurrent report06/04/26

Prospectuses and Registrations

424B5Prospectus supplement10/27/26 S-3ASRAutomatic shelf registration08/06/26 S-8Registration of securities for employees06/05/25 S-3Shelf registration02/27/25 424B3Prospectus12/31/24

Proxies

DEF 14ADefinitive proxy04/23/26 DEFA14AAdditional proxy materials04/23/26 DEF 14ADefinitive proxy04/24/25 DEFA14AAdditional proxy materials04/24/25 PRE 14APreliminary proxy04/14/25

Ownership

SC 13GBeneficial ownership09/21/26 SC 13G/ABeneficial ownership (amended)08/14/26 Form 4Insider transaction08/04/26 Form 4Insider transaction06/08/26 Form 4Insider transaction06/08/26

Other

ARSAnnual report to shareholders04/23/26 ARSAnnual report to shareholders04/24/25 EFFECTRequest for effectiveness03/07/25 CORRESPCorrespondence with the SEC03/05/25 UPLOADLetter from the SEC03/04/25